↑Flor PJ, Lindauer K, Puttner I, Ruegg D, Lukic S, Knopfel T, Kuhn R (1995). «Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2». Eur J Neurosci. 7 (4): 622–9. PMID7620613. doi:10.1111/j.1460-9568.1995.tb00666.x !CS1 manut: Nomes múltiplos: lista de autores (link)
Scherer SW, Duvoisin RM, Kuhn R; et al. (1997). «Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q.». Genomics. 31 (2): 230–3. PMID8824806. doi:10.1006/geno.1996.0036 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Gomeza J, Mary S, Brabet I; et al. (1996). «Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.». Mol. Pharmacol. 50 (4): 923–30. PMID8863838 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Snow BE, Hall RA, Krumins AM; et al. (1998). «GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain.». J. Biol. Chem. 273 (28): 17749–55. PMID9651375. doi:10.1074/jbc.273.28.17749 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Malherbe P, Knoflach F, Broger C; et al. (2001). «Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor.». Mol. Pharmacol. 60 (5): 944–54. PMID11641422 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Martí SB, Cichon S, Propping P, Nöthen M (2002). «Human metabotropic glutamate receptor 2 gene (GRM2): chromosomal sublocalization (3p21.1-p21.2) and genomic organization.». Am. J. Med. Genet. 114 (1): 12–4. PMID11840499. doi:10.1002/ajmg.1622 !CS1 manut: Nomes múltiplos: lista de autores (link)
Krampfl K, Schlesinger F, Zörner A; et al. (2002). «Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing.». Eur. J. Neurosci. 15 (1): 51–62. PMID11860506. doi:10.1046/j.0953-816x.2001.01841.x !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Dietrich D, Kral T, Clusmann H; et al. (2002). «Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus.». Neuropharmacology. 42 (3): 297–305. PMID11897108. doi:10.1016/S0028-3908(01)00193-9 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Kuwabara T, Hsieh J, Nakashima K; et al. (2004). «A small modulatory dsRNA specifies the fate of adult neural stem cells.». Cell. 116 (6): 779–93. PMID15035981. doi:10.1016/S0092-8674(04)00248-X !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Tang FR, Chia SC, Chen PM; et al. (2004). «Metabotropic glutamate receptor 2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, and of rats and mice after pilocarpine-induced status epilepticus.». Epilepsy Res. 59 (2-3): 167–80. PMID15246118. doi:10.1016/j.eplepsyres.2004.04.002 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Anneser JM, Chahli C, Ince PG; et al. (2004). «Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis.». J. Neuropathol. Exp. Neurol. 63 (8): 831–40. PMID15330338 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
{{citar periódico|autor =Cube RV, Vernier JM, Hutchinson JH, et al. |título=3-(2-Ethoxy-4-{3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2) |periódico=Bioorg. Med. Chem. Lett. |volume=15 |número= 9 |páginas= 2389–93 |ano= 2005 |pmid= 15837331 |doi= 10.1016/j.bmcl.2005.02.078 }}
Rodd ZA, McKinzie DL, Bell RL; et al. (2006). «The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats.». Behav. Brain Res. 171 (2): 207–15. PMID16678921. doi:10.1016/j.bbr.2006.03.032 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)